Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/11/1997 | US5602003 N-acetylglucosaminyltransferase V gene |
02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
02/11/1997 | US5601821 Histamine releasing peptide |
02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
02/11/1997 | CA1338902C Plant cells resistant to herbicidal glutamine synthetase inhibitors |
02/11/1997 | CA1338901C Recombinant dna sequences, vectors containing them and methods for the use thereof |
02/06/1997 | WO1997004315A1 Protein p5, a serum marker for brain damage |
02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
02/06/1997 | WO1997004119A1 Viral vectors and line for gene therapy |
02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
02/06/1997 | WO1997004116A1 Inhibition of cell respiration and production of male sterile plants |
02/06/1997 | WO1997004114A2 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
02/06/1997 | WO1997004113A2 Inhibition of gene expression |
02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
02/06/1997 | WO1997004103A2 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
02/06/1997 | WO1997004102A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
02/06/1997 | WO1997004094A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
02/06/1997 | WO1997004089A2 Porphyrin-accumulating type herbicide resistance gene |
02/06/1997 | WO1997004088A1 Porphyrin-accumulating type herbicide resistance gene |
02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
02/06/1997 | WO1997003999A1 Mutant s182 genes |
02/06/1997 | WO1997003998A1 Modulators of the function of fas receptors and other proteins |
02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
02/06/1997 | WO1997003574A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
02/06/1997 | WO1997003555A1 Transgenic animal model of osteopenia |
02/06/1997 | WO1996040924A3 Cotton fiber transcriptional factors |
02/06/1997 | WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
02/06/1997 | CA2227882A1 Protein p5, a serum marker for brain damage |
02/06/1997 | CA2227554A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
02/06/1997 | CA2227277A1 Porphyrin-accumulating type herbicide resistance gene |
02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
02/06/1997 | CA2226994A1 Inhibition of gene expression |
02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
02/06/1997 | CA2226625A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
02/06/1997 | CA2225481A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
02/06/1997 | CA2224736A1 Inhibition of cell respiration and production of male sterile plants |
02/06/1997 | CA2224289A1 New protein hmw human mp52s |
02/06/1997 | CA2200696A1 Viral vectors and line for gene therapy |
02/05/1997 | EP0757102A1 Genetic transformation using a PARP inhibitor |
02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
02/05/1997 | EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy |
02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
02/05/1997 | EP0756626A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines |
02/05/1997 | EP0756604A1 Melanoma antigens |
02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
02/05/1997 | EP0652895A4 Compounds which inhibit hiv replication. |
02/05/1997 | CN1142247A Extracorporeal ceel culture and transplantation kits |
02/04/1997 | US5599904 Encoded by dna carried on plsmid; glucocorticoid/mineralocorticoid/thyroid hormone/retinoic acid and estrogen related receptors |
02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
02/04/1997 | US5599707 Human prohibitin DNA |
02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
02/04/1997 | US5599705 In vitro method for producing differentiated universally compatible mature human blood cells |
02/04/1997 | US5599703 In vitro amplification/expansion of CD34+ stem and progenitor cells |
02/04/1997 | US5599682 Method for the protection of leucocytes and method of blood analysis |
02/04/1997 | US5599659 Preservation solution for ex vivo, warm preservation of tissues, explants,organs and vascular endothelial cells comprising retinal-derived fibroblast growth factor, cyclodextrin and chondroitin sulfate |
02/04/1997 | CA1338891C Recombinant dna methods, vectors and host cells |
01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
01/30/1997 | CA2226570A1 Enamel matrix related polypeptide |
01/30/1997 | CA2226490A1 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
01/29/1997 | EP0756006A2 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof |
01/29/1997 | EP0756003A1 Method of culturing animal cells |
01/29/1997 | EP0755924A1 Transportvehicles for macromolecules |
01/29/1997 | EP0755453A1 Dna regulatory elements responsive to cytokines |
01/29/1997 | EP0755449A1 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS |
01/29/1997 | EP0755446A1 Cardiotrophin and uses therefor |
01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |
01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
01/29/1997 | EP0755439A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
01/29/1997 | EP0755258A1 Methods of treating disease using sertoli cells and allografts or xenografts |
01/29/1997 | EP0755257A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
01/29/1997 | EP0673256A4 Suppression of myeloid cells. |
01/29/1997 | EP0641183A4 Coated transplant and method for making same. |
01/29/1997 | EP0542897B1 Producing monoclonal antibodies against human Vbeta T-cell receptor element using recombinant DNA vectors |
01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
01/29/1997 | EP0477290B1 Methods, compositions and devices for growing cells |
01/29/1997 | CN1141650A Macroencapsulated secretory cells |
01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
01/28/1997 | US5597726 Monoclonal antibodies reactive with a human atheroma associated antigen |
01/28/1997 | US5597711 Factor VIII binding domain of von Willebrand factor |
01/28/1997 | US5597710 Genetic engineering |
01/28/1997 | US5597705 DNA encoding thyroid hormone receptor compositions and methods |